0RA9.L
Based in Paris, France, ABIVAX Société Anonyme is a biopharmaceutical company dedicated to the discovery and optimization of novel drug treatments. Their research and development efforts primarily target inflammatory conditions, infectious diseases, and various forms of cancer. A central asset in their pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis and Crohn's Disease, and is also being investigated for COVID-19. The same compound is in Phase IIa trials for rheumatoid arthritis, having previously completed a Phase IIa study demonstrating viral remission in individuals with HIV. Additionally, Abivax is advancing ABX 196, an immune-enhancing ...[Read more]
Industry
Biotechnology
IPO Date
2016-09-30
Stock Exchange
LSE
Ticker
0RA9.L
According to Abivax S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -54.07. This represents a change of 1.45% compared to the average of -3.48 of the last 4 quarters.
The mean historical PE Ratio of Abivax S.A. over the last ten years is -8.41. The current -54.07 PE Ratio has changed 64.22% with respect to the historical average. Over the past ten years (40 quarters), 0RA9.L's PE Ratio was at its highest in in the June 2013 quarter at -0.01. The PE Ratio was at its lowest in in the June 2014 quarter at -65.06.
Average
-8.41
Median
-7.58
Minimum
-24.93
Maximum
-1.94
Discovering the peaks and valleys of Abivax S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 932.50%
Maximum Annual PE Ratio = -1.94
Minimum Annual Increase = -81.28%
Minimum Annual PE Ratio = -24.93
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -24.93 | 932.50% |
| 2024 | -2.41 | -15.67% |
| 2023 | -2.86 | 47.32% |
| 2022 | -1.94 | -81.28% |
| 2021 | -10.38 | -20.93% |
| 2020 | -13.13 | 46.15% |
| 2019 | -8.98 | 18.37% |
| 2018 | -7.59 | 0.26% |
| 2017 | -7.57 | 77.84% |
| 2016 | -4.26 | -50.36% |
The current PE Ratio of Abivax S.A. (0RA9.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-10.07
5-year avg
-8.51
10-year avg
-8.41
Abivax S.A.’s PE Ratio is less than Laboratorios Farmaceuticos Rovi, S.A. (16.15), greater than Oryzon Genomics S.A. (-89.17), less than Formycon AG (-14.04), less than Inventiva S.A. (-1.73), greater than Nanobiotix S.A. (-59.02), less than Transgene S.A. (-3.30), less than Valneva SE (-3.17), less than AB Science S.A. (-18.24), less than Vivoryon Therapeutics N.V. (-4.76), less than Vetoquinol S.A. (14.54),
| Company | PE Ratio | Market cap |
|---|---|---|
| 16.15 | N/A | |
| -89.17 | N/A | |
| -14.04 | N/A | |
| -1.73 | N/A | |
| -59.02 | N/A | |
| -3.30 | N/A | |
| -3.17 | N/A | |
| -18.24 | N/A | |
| -4.76 | N/A | |
| 14.54 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abivax S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abivax S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Abivax S.A.'s PE Ratio?
How is the PE Ratio calculated for Abivax S.A. (0RA9.L)?
What is the highest PE Ratio for Abivax S.A. (0RA9.L)?
What is the 3-year average PE Ratio for Abivax S.A. (0RA9.L)?
What is the 5-year average PE Ratio for Abivax S.A. (0RA9.L)?
How does the current PE Ratio for Abivax S.A. (0RA9.L) compare to its historical average?